Brinker Capital Inc. grew its holdings in Cigna Corp (NYSE:CI) by 18.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 55,399 shares of the health services provider’s stock after buying an additional 8,523 shares during the period. Brinker Capital Inc.’s holdings in Cigna were worth $8,409,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the company. Redhawk Wealth Advisors Inc. purchased a new position in Cigna during the second quarter worth about $28,000. Virtus ETF Advisers LLC purchased a new position in Cigna during the second quarter worth about $30,000. Garrett Wealth Advisory Group LLC purchased a new position in Cigna during the third quarter worth about $30,000. Optimum Investment Advisors raised its holdings in Cigna by 258.6% during the third quarter. Optimum Investment Advisors now owns 208 shares of the health services provider’s stock worth $32,000 after purchasing an additional 150 shares in the last quarter. Finally, TRUE Private Wealth Advisors purchased a new position in Cigna during the second quarter worth about $40,000. 87.45% of the stock is owned by institutional investors and hedge funds.
CI has been the subject of several analyst reports. Sanford C. Bernstein raised shares of Cigna from a “market perform” rating to an “outperform” rating and set a $205.00 price target for the company in a report on Tuesday, August 6th. ValuEngine raised shares of Cigna from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Oppenheimer set a $254.00 price target on shares of Cigna and gave the stock a “buy” rating in a report on Tuesday, September 10th. Morgan Stanley increased their price target on shares of Cigna from $207.00 to $208.00 and gave the stock an “overweight” rating in a report on Thursday, September 26th. Finally, Citigroup restated a “buy” rating on shares of Cigna in a research report on Wednesday, August 21st. Three equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $208.96.
CI traded up $0.52 on Monday, hitting $167.40. 52,894 shares of the company were exchanged, compared to its average volume of 2,201,664. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.70 and a current ratio of 0.70. The business’s fifty day moving average is $155.65 and its 200 day moving average is $159.11. Cigna Corp has a fifty-two week low of $141.95 and a fifty-two week high of $226.60. The firm has a market capitalization of $62.22 billion, a P/E ratio of 11.76, a price-to-earnings-growth ratio of 0.84 and a beta of 0.71.
Cigna (NYSE:CI) last issued its earnings results on Thursday, August 1st. The health services provider reported $4.30 earnings per share for the quarter, topping the consensus estimate of $3.74 by $0.56. Cigna had a net margin of 3.60% and a return on equity of 13.24%. The company had revenue of $34.38 billion for the quarter, compared to analyst estimates of $33.27 billion. During the same period in the prior year, the business posted $3.89 earnings per share. The firm’s revenue for the quarter was up 198.9% compared to the same quarter last year. Analysts forecast that Cigna Corp will post 16.77 EPS for the current fiscal year.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Article: Margin
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.